Spain Pharmaceuticals and Healthcare Report Q1 2015

BMI Research
December 31, 2014
99 Pages - SKU: BMI5432537
Countries covered: Spain

Spain Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The deterioration of the Spanish economy and the government's implementation of increasinglyaggressive fiscal austerity policies that focus on cost containment in the healthcare sector seriously hinderthe country's attractiveness to drugmakers. Despite calls made by companies for the implementation of asystem that adequately rewards innovation and supports investment in future medicines, the government islikely to remain committed to fiscal consolidation and will continue to target the pharmaceutical sector - alarge recipient of public healthcare expenditure.

Headline Expenditure Projections

Pharmaceuticals: EUR24.09bn (USD31.79bn) in 2013 to EUR23.03bn (USD30.85bn) in 2014; -4.4% inlocal currency terms and -3.0% in US dollar terms.

Healthcare: EUR101.79bn (USD134.37bn) in 2013 to EUR102.20bn (USD136.95bn) in 2014; +0.4% inlocal currency terms and +1.9% in US dollar terms.



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More Spain Prescription Drugs reports

Vancomycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Vancomycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
Valproic Acid: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Valproic Acid testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and ...
Topirimate: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Topirimate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
Tobramycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA by VPGMarketResearch.com
This new report from VPGMarketResearch.com provides analysis of Tobramycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!